Login

Interview with Fernando Lehner, CEO of BVZ Group, on the Business | Fernando Lehner - CEO of bvz holding ag 00:10:00

Share On Facebook Share On Twitter

Fernando Lehner is the CEO of bvz holding ag

Recent Videos

00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio
00:10:00
Jim Woody on Leading 180 Life Sciences: Advancing Breakthrough Biologic Therapies for Inflammation, Fibrosis, and Pain|Dr. Jim Woody,CEO,180 Life Sciences

Suggestions

00:10:00
Market Insights with Derek Kelly and James Igoe | Derek Kelly, CEO, Hilltop Financial Planning.
00:10:00
The Key Technique for Saving More Money: It's About Spending Wisely | Ken Robinson, Owner, Practical Financial Planning.
00:10:00
Paul Henrietti Reflects on Sanlam's Challenges and Future Amidst Global Turbulence | Paul Hanratty, CEO, Sanlam.
00:10:00
focusing on early-stage companies working on emergent tech|Mike W. Erwin,Founder, General Partner, and Chief Investment Officer,Ecliptic Capital
00:10:00
Israel's Wealth Growth and Economic Challenges | Tal Keinan, CEO and founder, Israel Clarity Capital.
00:10:00
Emerging Trends in Digital Marketing: Strategies for Success | Wol Kolade, Managing Partner, Livingbridge.
00:10:00
Interview with Founding Partners of Antares Vision: Insights from Emidio Zorzella and Massimo Bonardi | Emidio Zorzella - CEO of Antares Vision S.p.A.
00:10:00
Aston Minerals: Investigating Ontario's Gold and Nickel | Russell Bradford, Managing Director, Aston Minerals Ltd. (IE)
00:00:00
DR. DAVID BURTON Executive Chairman, CEO, Compumedics Ltd
00:10:00
Gold Terra Resource Corp.: High-Grade Gold Exploration in Canada's Northwest Territories
00:10:00
CEO of Ovzon Discusses Launch of Ofon 3 Satellite and Company's Leading Role in Mobile Satellite Communication | Per Norén, Ovzon.
00:10:00
Works on virtual and software-defined networking; productivity-based applications|Anik Bose,General Partner,Benhamou Global Ventures

© 2017 - Neuhu+